<DOC>
	<DOC>NCT00627809</DOC>
	<brief_summary>The investigators hypothesized that complementary intracoronary streptokinase administration to primary percutaneous intervention in patients with acute myocardial infarction may provide limitation infarct size and improvement in left ventricular volumes and function in acute and late phases (6 months).</brief_summary>
	<brief_title>Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Streptokinase</mesh_term>
	<criteria>Continuous chest pain that lasted &gt; 30 minutes within the preceding 12 hours STsegment elevation of at least 1 mm in 2 contiguous leads on the ECG Infarct related artery (IRA) occlusion (TIMI grade 0) at the angiography Contraindications to streptokinase, tirofiban, aspirin, clopidogrel, or heparin Culprit lesion in saphenous vein graft TIMI grade IIIII flow in IRA Additional epicardial stenosis in the IRA distal to stented segment (significant or insignificant) Presence of left bundle branch block History of prior MI</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>coronary microcirculation</keyword>
	<keyword>acut myocardial infarction</keyword>
	<keyword>infarct size</keyword>
	<keyword>streptokinase</keyword>
	<keyword>reperfusion</keyword>
</DOC>